Literature DB >> 30339628

Comprehensive Complication Index Validates Improved Outcomes Over Time Despite Increased Complexity in 3707 Consecutive Hepatectomies.

Jordan M Cloyd1, Takashi Mizuno1, Yoshikuni Kawaguchi1, Heather A Lillemoe1, Georgios Karagkounis1, Kiyohiko Omichi1, Yun Shin Chun1, Claudius Conrad1, Ching-Wei D Tzeng1, Bruno C Odisio2, Steven Y Huang2, Marshall Hicks2, Steven H Wei1, Thomas A Aloia1, Jean-Nicolas Vauthey1.   

Abstract

OBJECTIVE: The aim of this study was to evaluate trends over time in perioperative outcomes for patients undergoing hepatectomy.
BACKGROUND: As perioperative care and surgical technique for hepatectomy have improved, the indications for and complexity of liver resections have evolved. However, the resulting effect on the short-term outcomes over time has not been well described.
METHODS: Consecutive patients undergoing hepatectomy during 1998 to 2015 at 1 institution were analyzed. Perioperative outcomes, including the comprehensive complication index (CCI), were compared between patients who underwent hepatectomy in the eras 1998 to 2003, 2004 to 2009, and 2010 to 2015.
RESULTS: The study included 3707 hepatic resections. The number of hepatectomies increased in each era (794 in 1998 to 2003, 1402 in 2004 to 2009, and 1511 in 2010 to 2015). Technical complexity increased over time as evidenced by increases in the rates of major hepatectomy (20%, 23%, 30%, P < 0.0001), 2-stage hepatectomy (0%, 3%, 4%, P < 0.001), need for portal vein embolization (5%, 9%, 9%, P = 0.001), preoperative chemotherapy for colorectal liver metastases (70%, 82%, 89%, P < 0.001) and median operative time (180, 175, 225 minutes, P < 0.001). Significant decreases over time were observed in median blood loss (300, 250, 200 mL, P < 0.001), transfusion rate (19%, 15%, 5%, P < 0.001), median length of hospitalization (7, 7, 6 days, P < 0.001), rates of CCI ≥26.2 (20%, 22%, 16%, P < 0.001) and 90-day mortality (3.1%, 2.6%, 1.3%, P < 0.01). On multivariable analysis, hepatectomy in the most recent era 2010 to 2015 was associated with a lower incidence of CCI ≥26.2 (odds ratio 0.7, 95% confidence interval 0.6-0.8, P < 0.0001).
CONCLUSION: Despite increases in complexity over an 18-year period, continued improvements in surgical technique and perioperative outcomes yielded a resultant decrease in CCI in the most current era.

Entities:  

Mesh:

Year:  2020        PMID: 30339628      PMCID: PMC6864233          DOI: 10.1097/SLA.0000000000003043

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   13.787


  54 in total

1.  Liver hanging maneuver: a safe approach to right hepatectomy without liver mobilization.

Authors:  J Belghiti; O A Guevara; R Noun; P F Saldinger; R Kianmanesh
Journal:  J Am Coll Surg       Date:  2001-07       Impact factor: 6.113

2.  Hepatic atrophy following preoperative chemotherapy predicts hepatic insufficiency after resection of colorectal liver metastases.

Authors:  Suguru Yamashita; Junichi Shindoh; Takashi Mizuno; Yun Shin Chun; Claudius Conrad; Thomas A Aloia; Jean-Nicolas Vauthey
Journal:  J Hepatol       Date:  2017-02-10       Impact factor: 25.083

3.  Postoperative liver failure after major hepatic resection for hepatocellular carcinoma in the modern era with special reference to remnant liver volume.

Authors:  K Shirabe; M Shimada; T Gion; H Hasegawa; K Takenaka; T Utsunomiya; K Sugimachi
Journal:  J Am Coll Surg       Date:  1999-03       Impact factor: 6.113

4.  Association of computed tomography morphologic criteria with pathologic response and survival in patients treated with bevacizumab for colorectal liver metastases.

Authors:  Yun Shin Chun; Jean-Nicolas Vauthey; Piyaporn Boonsirikamchai; Dipen M Maru; Scott Kopetz; Martin Palavecino; Steven A Curley; Eddie K Abdalla; Harmeet Kaur; Chusilp Charnsangavej; Evelyne M Loyer
Journal:  JAMA       Date:  2009-12-02       Impact factor: 56.272

5.  Patient-Reported Outcomes Accurately Measure the Value of an Enhanced Recovery Program in Liver Surgery.

Authors:  Ryan W Day; Charles S Cleeland; Xin S Wang; Sharon Fielder; John Calhoun; Claudius Conrad; Jean-Nicolas Vauthey; Vijaya Gottumukkala; Thomas A Aloia
Journal:  J Am Coll Surg       Date:  2015-10-21       Impact factor: 6.113

6.  Hepatic insufficiency and mortality in 1,059 noncirrhotic patients undergoing major hepatectomy.

Authors:  John T Mullen; Dario Ribero; Srinevas K Reddy; Matteo Donadon; Daria Zorzi; Shiva Gautam; Eddie K Abdalla; Steven A Curley; Lorenzo Capussotti; Bryan M Clary; Jean-Nicolas Vauthey
Journal:  J Am Coll Surg       Date:  2007-02-15       Impact factor: 6.113

7.  Kinetic growth rate after portal vein embolization predicts posthepatectomy outcomes: toward zero liver-related mortality in patients with colorectal liver metastases and small future liver remnant.

Authors:  Junichi Shindoh; Mark J Truty; Thomas A Aloia; Steven A Curley; Giuseppe Zimmitti; Steven Y Huang; Armeen Mahvash; Sanjay Gupta; Michael J Wallace; Jean-Nicolas Vauthey
Journal:  J Am Coll Surg       Date:  2012-12-07       Impact factor: 6.113

8.  One thousand fifty-six hepatectomies without mortality in 8 years.

Authors:  Hiroshi Imamura; Yasuji Seyama; Norihiro Kokudo; Atsushi Maema; Yasuhiko Sugawara; Keiji Sano; Tadatoshi Takayama; Masatoshi Makuuchi
Journal:  Arch Surg       Date:  2003-11

9.  Portal vein embolization before right hepatectomy: prospective clinical trial.

Authors:  Olivier Farges; Jacques Belghiti; Reza Kianmanesh; Jean Marc Regimbeau; Roberto Santoro; Valérie Vilgrain; Alban Denys; Alain Sauvanet
Journal:  Ann Surg       Date:  2003-02       Impact factor: 12.969

10.  Remnant Liver Ischemia as a Prognostic Factor for Cancer-Specific Survival After Resection of Colorectal Liver Metastases.

Authors:  Suguru Yamashita; Aradhana M Venkatesan; Takashi Mizuno; Thomas A Aloia; Yun S Chun; Jeffrey E Lee; Jean-Nicolas Vauthey; Claudius Conrad
Journal:  JAMA Surg       Date:  2017-10-18       Impact factor: 14.766

View more
  13 in total

1.  Contemporary indications for and outcomes of hepatic resection for neuroendocrine liver metastases.

Authors:  Steven D Scoville; Dimitrios Xourafas; Aslam M Ejaz; Allan Tsung; Timothy Pawlik; Jordan M Cloyd
Journal:  World J Gastrointest Surg       Date:  2020-04-27

2.  Big size is not all, even better!

Authors:  Roberto Ivan Troisi; Mariano Cesare Giglio; Roberto Montalti
Journal:  Hepatobiliary Surg Nutr       Date:  2019-10       Impact factor: 7.293

3.  Hepatectomy: more complex operations and improved perioperative outcomes.

Authors:  Laleh Melstrom
Journal:  Hepatobiliary Surg Nutr       Date:  2019-08       Impact factor: 7.293

Review 4.  Neuroendocrine liver metastases: a contemporary review of treatment strategies.

Authors:  Jordan M Cloyd; Aslam Ejaz; Bhavana Konda; Mina S Makary; Timothy M Pawlik
Journal:  Hepatobiliary Surg Nutr       Date:  2020-08       Impact factor: 7.293

5.  Minimally invasive versus open hepatectomy for the resection of colorectal liver metastases: a systematic review and meta-analysis.

Authors:  Ahmad Ozair; Amelia Collings; Alexandra M Adams; Rebecca Dirks; Bradley S Kushner; Iswanto Sucandy; David Morrell; Ahmed M Abou-Setta; Timothy Vreeland; Jake Whiteside; Jordan M Cloyd; Mohammed T Ansari; Sean P Cleary; Eugene Ceppa; William Richardson; Adnan Alseidi; Ziad Awad; Subhashini Ayloo; Joseph F Buell; Georgios Orthopoulos; Samer Sbayi; Go Wakabayashi; Bethany J Slater; Aurora Pryor; D Rohan Jeyarajah
Journal:  Surg Endosc       Date:  2022-09-22       Impact factor: 3.453

6.  Liver resection for hepatocellular carcinoma in patients with clinically significant portal hypertension.

Authors:  Daniel Azoulay; Emilio Ramos; Margarida Casellas-Robert; Chady Salloum; Laura Lladó; Roy Nadler; Juli Busquets; Celia Caula-Freixa; Kristel Mils; Santiago Lopez-Ben; Joan Figueras; Chetana Lim
Journal:  JHEP Rep       Date:  2020-10-08

7.  Development of a severe mesenteric traction syndrome during major abdominal surgery is associated with increased postoperative morbidity: Secondary data analysis on prospective cohorts.

Authors:  August A Olsen; Rune B Strandby; Nikolaj Nerup; Rikard Ambrus; Jens Peter Gøtze; Lars Bo Svendsen; Michael P Achiam
Journal:  Langenbecks Arch Surg       Date:  2019-12-09       Impact factor: 3.445

Review 8.  Debate: Improvements in Systemic Therapies for Liver Metastases Will Increase the Role of Locoregional Treatments.

Authors:  Yoshikuni Kawaguchi; Mario De Bellis; Elena Panettieri; Gregor Duwe; Jean-Nicolas Vauthey
Journal:  Surg Oncol Clin N Am       Date:  2020-10-27       Impact factor: 3.495

9.  Trends in Textbook Outcomes over Time: Are Optimal Outcomes Following Complex Gastrointestinal Surgery for Cancer Increasing?

Authors:  J Madison Hyer; Joal D Beane; Gaya Spolverato; Diamantis I Tsilimigras; Adrian Diaz; Alessandro Paro; Djhenne Dalmacy; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2021-09-10       Impact factor: 3.452

10.  The comprehensive complication index (CCI): proposal of a new reporting standard for complications in major urological surgery.

Authors:  K F Kowalewski; D Müller; J Mühlbauer; J D Hendrie; T S Worst; F Wessels; M T Walach; J von Hardenberg; P Nuhn; P Honeck; M S Michel; M C Kriegmair
Journal:  World J Urol       Date:  2020-08-19       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.